
Sebastian Schmidt: Declining mortality in lung cancer – a beacon of hope
Sebastian Schmidt, Head of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers, posted on LinkedIn:
“Declining mortality in lung cancer – a beacon of hope.
I made a little chart for my presentation at the European Society of Thoracic Imaging (ESTI) conference in Berlin today that I wanted to share with you.
The chart shows an analysis of the US cancer statistics (SEER data). The orange line is the incidence per 100k inhabitants (cases of lung cancer), scale on the left. The black line is lung cancer mortality (deaths from lung cancer). The grey bars are the Mortality/Incidence ratio, which gives an estimate of what percentage of patients die from the disease.
What do we see:
– Mortality and incidence were largely parallel over a longer time (actually longer than the period shown here). The Mortality/Incidence ratio therefore almost constantly >80%, little to no improvement. Consider this is a time period when we saw enormous improvements in breast cancer and many other cancers.
– Late 90s, incidence started to go down. This is surely an effect of the tobacco control measures introduced in the 70s. Tobacco control works, but of course with a 20-year latency. Mortality still parallel. MIR above 80%.
– Around 2014, the MIR started declining – mortality went down faster than incidence. This is a sign that survival of patient finally improves, after so many years of little change.
Two effects likely have contributed: New drugs, mainly immuno-oncological, improved survival. And the USPSTF recommended lung screening, the screening programs started, which increased the share of early-stage diagnosis.
Could overdiagnosis play a role? Rather unlikely – the typical sign for large-scale overdiagnosis in screening programs is increasing incidence with constant mortality. We don’t see increasing incidence here – the curve declines evenly, following the reduction in smoking 20 years earlier. And the mortality is obviously declining.
This is positive news and should encourage more countries to take up lung cancer screening. ”
Source: Sebastian Schmidt/LinkedIn
-
12:46 30/11/23 | BlogJohanna Joyce: the Flashlight method
-
12:31 30/11/23 | InsightJeff Ryckman: Omitting RT in bulky early-stage cHL
-
07:45 30/11/23 | BlogAaron Goodman: Hemoglobin Dissociation Curve! Good stuff
-
12:31 30/11Jeff Ryckman: Omitting RT in bulky early-stage cHL
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows